key: cord-0736393-kron7wny
authors: Krishnan, Shuba; Nordqvist, Hampus; Ambikan, Anoop T.; Gupta, Soham; Sperk, Maike; Svensson-Akusjärvi, Sara; Mikaeloff, Flora; Benfeitas, Rui; Saccon, Elisa; Ponnan, Sivasankaran Munusamy; Rodriguez, Jimmy Esneider; Nikouyan, Negin; Odeh, Amani; Ahlén, Gustaf; Asghar, Muhammad; Sällberg, Matti; Vesterbacka, Jan; Nowak, Piotr; Végvári, Ákos; Sönnerborg, Anders; Treutiger, Carl Johan; Neogi, Ujjwal
title: Implications of central carbon metabolism in SARS-CoV-2 replication and disease severity
date: 2021-02-24
journal: bioRxiv
DOI: 10.1101/2021.02.24.432759
sha: 977af5fca12dffaa58ee2c262f4619afdf3cff46
doc_id: 736393
cord_uid: kron7wny

Viruses hijack host metabolic pathways for their replicative advantage. Several observational trans-omics analyses associated carbon and amino acid metabolism in coronavirus disease 2019 (COVID-19) severity in patients but lacked mechanistic insights. In this study, using patient- derived multi-omics data and in vitro infection assays, we aimed to understand i) role of key metabolic pathways in severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2) reproduction and ii) its association with disease severity. Our data suggests that monocytes are key to the altered immune response during COVID-19. COVID-19 infection was associated with increased plasma glutamate levels, while glucose and mannose levels were determinants of the disease severity. Monocytes showed altered expression pattern of carbohydrate and amino acid transporters, GLUT1 and xCT respectively in severe COVID-19. Furthermore, lung epithelial cells (Calu-3) showed a strong acute metabolic adaptation following infection in vitro by modulating central carbon metabolism. We found that glycolysis and glutaminolysis are essential for virus replication and blocking these metabolic pathways caused significant reduction in virus production. Taken together, our study highlights that the virus utilizes and re-wires pathways governing central carbon metabolism leading to metabolic toxicity. Thus, the host metabolic perturbation could be an attractive strategy to limit the viral replication and disease severity.

The global pandemic of coronavirus disease 2019 caused by the severe acute 49 respiratory syndrome coronavirus-2 (SARS-CoV-2) created a severe public health crisis 50 worldwide. Although most patients presented with mild to moderate or no symptoms, patients 51 having pre-existing metabolic disorders like diabetes, cardiovascular diseases, and obesity are at 52 risk for severe and critical cases of infection. Some recent observational studies indicate that 53 disease severity in COVID-19 patients are associated with plasma metabolic abnormalities that 54 include a shift towards amino acid and fatty acid synthesis, altered energy and lipid metabolism 55 [1] [2] [3] and metabolic profile can identify the disease severity [4] . However, metabolic regulation 56 of an individual always depends on several factors including age, gender, environmental factors, 57 dietary intake and lifestyle. Such alterations in metabolic regulation can change rapidly or adapt 58 to an altered situation and sometimes have sustained effects over an extended period. The initial 59 phase of characterization of the metabolic landscape of COVID-19 and its association with 60 disease severity has urged the need to understand how metabolic reprogramming occurs during 61 the acute SARS-CoV-2 infection with the ultimate goal towards therapeutic intervention. 62

Viruses are known to exploit the host metabolic machinery to meet their biosynthetic demands 63 for optimal replication capacity. This cellular exploration is highly connected with the initial 64 host-viral response, thereby determining the disease pathogenesis. Viral replication is dependent 65 on extracellular carbon sources such as glucose and glutamine. It induces a plethora of metabolic 66 alterations in host-cell including host central carbon metabolism, nucleotide, fatty acids and lipid 67 synthesis that modulate viral pathogenesis and host-response [5, 6] . Recent in vitro multi-omics 68 studies have shown that the SARS-CoV-2 dysregulates PI3K/Akt/mTOR and HIF-1 signaling in 69 infected cells. These pathways regulate glycolysis by altering glucose transporters (GLUT) across 70 1 2 compared to HCs (Fig S6) . This indicated an impact of SARS-CoV-2 infection on glycolysis and 231 glutaminolysis to meet biosynthetic and bioenergetic demands. In order to determine the 232 requirement of glycolysis and glutaminolysis for optimal replication of SARS-CoV-2 in Calu-3 233 cells, we blocked these pathways using 2-DG and 6-diazo-5-oxo-L-norleucine (DON) 234 respectively (Fig 5e) following infection. Infectivity of SARS-CoV-2, quantified as relative E-235 gene levels in cells lysates, showed ~50-fold decrease in 2-DG treated cells and >100-fold 236 decrease in DON treated cells (Fig 5f) . This was also corroborated with virus production in the 237 cell culture supernatant, quantified by viral E-gene levels that decreased by more than 2log10 238 RNA copies/ml in both 2-DG and DON treated cells compared to untreated cells (Fig 5g) . While 239 several studies have shown the role of glycolysis on SARS-CoV-2 infection [14, 15] , so far there 240 is no direct evidence linking the role of glutaminolysis to replication and spread of SARS-CoV-2 241 and here we show for the first time that both glutaminolysis and glycolysis are essential for 242 SARS-CoV-2 infection. 243

To understand the role of sugars like glucose and mannose in SARS-CoV-2 infection, we 245 performed in vitro infection assays in Calu-3 cells with varying media concentrations of glucose 246 (11.1, 22.2, 44.4mM ) and mannose (0, 11.1, 22.2, 44.4mM ) with 0.001moi. We did not observe 247 any statistically significant difference in virus production in the supernatant in the 248 glucose/mannose concentrations tested (p>0.05, Fig 6a) , while we found a significant reduction 249 in viral E-gene expression at cellular level with high glucose concentration of 44.4 mM (Fig 6b,  250 p<0.05). Supplementation with high mannose did not cause any significant change in expression 251

of the E-gene. Overall, our data indicate that increased glucose levels but not mannose levels has 252 an effect on viral replication in vitro. 1 3 Several studies, including ours, have shown an effect of SARS-CoV-2 infection on complement 254 and coagulation cascades and thrombosis as unique features of 19, 20] . 255 Temporal transcriptomic and proteomic profiling of SARS-CoV-2 infected Huh7 cells have also 256 revealed an upregulation of proteins involved in complement activation at a later stage of 257 infection [20] . Since complement component C4 is part of the cascade that leads to C3 activation 258 in the classical and MBL pathways, we also studied whether increased glucose/mannose in the 259 media during infection affected upstream events of C3 activation (Fig 6c) . This was performed by 260 determining gene expression levels of MBL associated serine protease 2 (MASP2) and 261 complement C4 in Calu-3 cells infected with SARS-CoV-2 (moi 0.001) at different 262 concentrations of glucose and mannose. Mannose availability in the culture medium slightly 263 reduced gene expression of MASP2 in mock-infected that increased upon infection. However no 264 significant changes in MASP2 expression were observed compared to the basal condition (Fig  265   6d ). An interesting trend was observed with C4 gene expression (Fig 6e) . In mock-infected cells, 266

we observed an increase in C4 expression with increasing glucose concentrations that decreased 267 dose-dependently following addition of mannose. In the infected cells, a general increase was 268 detected in C4 expression compared to mock that also followed a similar trend in different 269 glucose and mannose concentrations as was observed in mock-infected cells (Fig 6e) . Since 270 COVID-19 patients in this study had high plasma concentrations of glucose and mannose, we 271 also measured MASP2 and C4 gene expression in whole blood originating from these patients. 272

No change was observed in MASP2 expression while a significant decrease in C4 expression was 273 observed in COVID-19 severe patients compared to HCs (Fig 6f and 6g) 

In this study, we used metabolomics, proteomics and immunophenotyping to observe the effect 281 of SARS-CoV-2 infection on metabolic dysregulation in COVID-19 patients and performed in 282 vitro infection in four different cell models to find out potential host metabolic regulation during 283 acute SARS-CoV-2 infection. Our study has shed light on the role of monocytes, especially in 284 severe COVID-19 disease. As expected, COVID-19 patients presented a cytokine storm. 285

Interestingly IL-12 plasma levels were decreased in severe compared to mild COVID-19 patients. 286

Among the carbohydrates, plasma mannose emerged as a biomarker for disease severity, but in 287 vitro assays showed no effect of mannose on viral replication. Furthermore, host cellular response 288 following SARS-CoV-2 infection identified a strong acute metabolic adaptation in the lung 289 epithelial cells (Calu-3) by modulating central carbon metabolism and indicative of mitochondrial 290 dysfunction that is also observed in severe COVID-19 patients. Glycolysis and glutaminolysis are 291 essential for virus replication and metabolic perturbations of these processes can impede SARS-292

CoV-2 and could be an attractive antiviral strategy. Finally, SARS-CoV-2 potentially regulates 293 the C4 system transcriptionally in the presence of carbohydrates. 294

As reported, the cytokine storm syndrome is evident in COVID-19 patients [21, 22] . Several 295 plasma pro-inflammatory cytokines including IL-6 were elevated in both mild and severe 296 COVID-19 patients. In our study, though we observed higher levels of soluble IL-12 in mild 297 patients, the severe patients showed IL-12 levels similar to HCs. Elevated plasma levels of IL-12 298 have also been described in hospitalized patients infected with other coronaviruses, such as 1 5 SARS-CoV and Middle East respiratory syndrome coronavirus (MERS-CoV) [23, 24] . However, 300 to our knowledge, no associations of IL-12 levels with disease severity were reported in these 301

infections. In a recent study on COVID-19 patients on ventilators, the reported low level of IL-12 302 could be caused by impaired monocytes and affect natural killer (NK) cell functions [25, 26] . In 303 vitro studies on IL-12 administration have shown enhanced host cellular responses that generally 304 promote virus clearance and host recovery from infection [27] . IL-12 also plays a critical role in 305 viral immunity by activating the NK cells and promoting differentiation of Th1 CD4 + T-cells. 306

Based on the different levels of IL-12 in COVID-19 patients at varying disease stages, its role in 307 disease severity needs further attention. 308

Both DNA and RNA viruses rewire host cell metabolism by altering central carbon metabolic 309 pathways such as glycolysis, gluconeogenesis, PPP, TCA cycle, amino acid 310 synthesis/degradation, and lipid synthesis. In our metabolomics data, we observed increased 311 glucose, pyruvate and lactate levels in the plasma of COVID-19 patients compared to HCs 312 indicative of toxic metabolic dysregulation during acute phase of infection. Under aerobic, 313 standard growth conditions, primary mammalian cells use glucose for generation of ATP. 314

Glucose is enzymatically broken down to pyruvate that can feed into the TCA cycle in the 315 mitochondria ultimately driving electron transport chain to generate ATP with the help of 316 oxygen. 317 Viral infections including SARS-CoV-2 are known to enhance the glycolytic flux and increase 318 the production of lactate from pyruvate [6, 28, 29] . Viruses can target glycolysis by regulating 319 glucose transporters' expression, which is also vital for immune cell activation during host 320 cellular response [30, 31] . Increased GLUT1 does not only result in higher glucose uptake but 321 also gives rise to increased PPP intermediates that enhance nucleotide pool required for viral 322 replication [5] . GLUT1 transports glucose, mannose, glucosamine and docosahexaenoic acid noted. To the best of our knowledge, the association of xCT expression in respiratory viral 330 diseases has not been studied before and our data for the first time highlights the crucial role of 331 expression of xCT in monocytes. A growing body of evidence highlights the potential role and 332 metabolic status of monocytes in COVID-19 disease severity [4, 13, 33] . Combining all the data, 333 metabolite transporters, xCT and GLUT1, play an essential role in disease severity that could be 334 linked to higher plasma glucose and mannose levels. The specific changes of metabolic 335 transporters were more prominent in monocytes, indicating that metabolic profile of the different 336 monocytic sub-populations could contribute to mediating the severity of the disease. 337

Plasma mannose emerges as a robust biomarker of disease severity and can also lead to activation 338 of the lectin complement system at a later stage of infection [20] . In addition to mannose, we also 339 observed increased levels of MBL in both COVID-19 patients and convalescent patients 340 compared to the COVID-19 negative individuals. However, no correlation between plasma MBL 341 and mannose were observed in COVID-19 and these two can very well be independent factors. 342

Monomeric mannose is a crucial element of N-linked glycosylation of proteins. Recent studies 343 reported that plasma mannose levels were an indicator of glycogenolysis as well as glucose 344 tolerance and associated with the future risk of developing chronic diseases such as type 2 345 diabetes, cardiovascular diseases, and albuminuria [34, 35] . In our study cohort, the incidence of 346 type 2 diabetes was low in all study groups and can therefore not explain the high plasma 1 7 mannose levels in COVID-19 patients. This further strongly suggests that increased mannose is 348 an effect of SARS-CoV-2 infection. However, in light of recent research indicating a possibility 349 of a bidirectional link between SARS-CoV-2 and diabetes, it is tempting to speculate that 350 increased mannose has a role to play in new-onset diabetes after SARS-CoV-2 infection [36] [37] [38] [39] . Finally, authors state that MBL signaling contributes to disease severity through complement 363 cascade activation and inflammatory response. High mannose and/or high MBL could thus 364 dysregulate the immune system and lead to severe damage associated with disease severity [42] . 365

Activation of the complement is one of the features seen in COVID-19, as described in earlier 366 studies [7, 43] . In concordance with that and with Heindel et al., we also noticed increased 367 plasma MBL in COVID-19 and even in healthy convalescent controls compared to HC. This 368 increase in MBL could potentially regulate the complement cascade. 369

In the in vitro Calu-3 infection model, most of the proteins from carbohydrate metabolism and 370 PPP were upregulated while most of the proteins of TCA cycle, oxidative phosphorylation, and 1 8 fatty acid metabolism were downregulated in infected cells compared to the mock-infected 372 controls ( Fig 5) . Further delineation of the pathways indicated an inefficient mitochondrial 373 metabolism as majority of the TCA cycle enzymes were downregulated in the infected cells. This 374 was in line with the decreased mtDNA copy numbers in severe COVID-19 patients (Fig 5f)  375 indicating a possible mitochondrial dysfunction as reported previously [13, [44] [45] [46] . 376

The metabolism and concentration of sugars and amino acids such as glucose, mannose, 377 glutamine and glutamate among others, play an important role in cellular metabolic homeostasis 378 and are targeted by viruses for their replication. Recent studies have shown that elevated 379 glycolysis favors SARS-CoV-2 infection and replication [14, 15] . While glutaminolysis has been 380 implicated as a carbon source for other human DNA and RNA viruses [5] . Our data shows for the 381 first time that glutaminolysis is also crucial for SARS-CoV-2 infection and replication. The 382

inhibition of glutaminolysis has a larger effect on viral replication and production compared to 383 the inhibition of the glycolysis in lung cell model (Fig 5f and 5g ). Glutaminolysis is a process of 384 converting glutamine to TCA cycle intermediates and also essential for biosynthesis of proteins, 385 lipids and nucleic acids. Some viruses (e.g. Herpes simplex virus 1, human cytomegalovirus, 386

Hepatitis C virus etc) use glutamine as an anaplerotic substrate to replenish TCA cycle via 387 generation of α -ketoglutarate [29, 47] . Recently, researchers have proposed that the metabolic 388 reprogramming of glutamine in SARS-CoV-2 can trigger pathogenesis. They further 389 hypothesized that metabolic intervention of glutaminolysis could be an antiviral strategy for 390 . Although the exact underlying mechanism is unknown, our in vitro study 391

shows that SARS-CoV-2 replication depends on both glycolysis and glutaminolysis. 392 

In 6-well plate, Calu-3 cells were grown for 72h, and 513

Huh7, 293FT, and Caco-2 cells were grown for 24h in DMEM-high glucose (Sigma-Aldrich, 514 USA) supplemented with 10% FBS (Gibco, USA). The cells were either mock-infected in 515 medium only or infected with SARS-CoV-2 at a multiplicity of infection (moi) of 1 in DMEM-516 high glucose supplemented with 5% FBS. After 1h the inoculum was removed and was 517 replenished with 2mL of fresh DMEM-high glucose containing 5% FBS. Twenty-four hours 518 post-infection (hpi) the supernatant was removed, and the cells were scrapped in 1mL PBS, 519 centrifuged and the washed cell pellets were lysed in 100µL of 2% SDS-lysis buffer (50mM Tris-520

Cl, 150mM NaCl, 2% SDS and 1mM EDTA) freshly supplemented with protease inhibitor 521 cocktail, phosphatase inhibitor and 1mM DTT. The lysates were heated at 92 o C for 10min to 522 deactivate the virus, followed by sonication in a water-bath sonicator for 2min to clear the lysate. 523

Lysates were centrifuged at 13,000rpm for 15min and supernatants were collected. Protein 524 estimation was performed by Bio-rad DC protein assay kit (Bio-Rad Laboratories, USA). The 525 supernatant proteins were used for in-solution digestion and TMT-pro labeled proteomics as 526 described by us previously [7] . 527

after 72h of seeding, the cells were infected with SARS-CoV-2 at moi of 0.001 for 1h. Following Research, USA). The supernatant or RNA were directly used for one-step RT-qPCR using 541

PrimeDirect™ Probe RT-qPCR Mix (TaKaRa, Japan) according to manufacturer's instructions. 542

Primer and probe sequences for the viral E-gene and human RNaseP gene are listed in Table S3 . 543

To measure gene expression of MASP2 and C4 in patient blood, whole blood was collected in 544 Tempus™ Blood RNA Tubes (Applied Biosystems, USA) and RNA was extracted using 545 Tempus™ Spin RNA Isolation Kit (Invitrogen, USA). Quality and concentration of extracted 546 RNA was measured using Nanodrop ND-2000 (Thermo Scientific, USA). 547

The RNA purified from cells and whole blood was reverse transcribed using a High-Capacity 548 cDNA reverse transcription kit (Applied Biosystems, USA) according to manufacturer's 549 instructions. qPCR reactions were performed using KAPA SYBR Fast qPCR kit (KAPA 550 Biosystems, USA) on an Applied Biosystems™ 7500 Fast qPCR machine. Detailed information 551 on primers is included in Table S3 Table S1 . Clinical Features of the study population 896 Table S2 : List of reagents, kits and antibodies 897 

CoV-2-infected host cells reveals therapy targets

CoV-2 and mitochondrial health: implications of lifestyle and ageing

Replication 628 dynamics and cytotoxicity of SARS-CoV-2 Swedish isolate in commonly used laboratory cell 629 lines

Mitochondrial 631 DNA copy number is associated with mortality and infections in a large cohort of patients with 632 chronic kidney disease

Cytokine storm syndrome in coronavirus disease 2019: 644 A narrative review

The COVID-19 Cytokine

Comparative and kinetic 651 analysis of viral shedding and immunological responses in MERS patients representing a broad 652 spectrum of disease severity

Plasma inflammatory 655 cytokines and chemokines in severe acute respiratory syndrome

Severe COVID-19 Is Marked by a Dysregulated Myeloid Cell Compartment

Impaired natural killer cell counts and cytolytic activity in patients with severe COVID-19

Autoantibody-711 negative insulin-dependent diabetes mellitus after SARS-CoV-2 infection: a case report

COVID-19 infection may cause ketosis 715 and ketoacidosis

Deducing the N-and O-glycosylation 718 profile of the spike protein of novel coronavirus SARS-CoV-2

Mannose efflux from the cells: a potential source of mannose in 722 blood

Glycomic 725 analysis of host response reveals high mannose as a key mediator of influenza severity

The 729 complement system in COVID-19: friend and foe? JCI insight

Mitochondrial induced T cell apoptosis and aberrant myeloid metabolic programs define distinct 733 immune cell subsets during acute and recovered SARS-CoV-2 infection

Decoding SARS-CoV-2 hijacking of host 737 mitochondria in COVID-19 pathogenesis

Circulating mitochondrial 741 DNA is an early indicator of severe illness and mortality from COVID-19

Host cell glutamine metabolism as a potential antiviral target

Can a metabolism-targeted therapeutic intervention successfully 748 subjugate SARS-COV-2? A scientific rational

The key role of Warburg 752 effect in SARS-CoV-2 replication and associated inflammatory response

Detection and Isolation of SARS-756

CoV-2 in Serum, Urine, and Stool Specimens of COVID-19 Patients from the Republic of Korea

SARS-CoV-2-Specific Antibody-Secreting Cells and Generation of Neutralizing Antibodies in 762

Hospitalized COVID-19 Patients

Tissue-based map of the human proteome

Attacking the defence: SARS-CoV-2 can infect immune cells

Epub 2020/08/23

Marburg virus regulates the IRE1/XBP1-dependent 772 unfolded protein response to ensure efficient viral replication

SARS-CoV-2 infections in engineered human tissues using clinical-grade soluble human ACE2

Metabolic Signature and Abnormalities in HIV-Infected Individuals on Long-Term Successful 780

UMAP: uniform manifold approximation 783 and projection

Elegant Graphics for Data Analysis -ggplot2

limma powers differential 787 expression analyses for RNA-sequencing and microarray studies

Variable selection and validation 791 in multivariate modelling

Enrichr: a 795 comprehensive gene set enrichment analysis web server 2016 update

Gene 799 set enrichment analysis: a knowledge-based approach for interpreting genome-wide expression 800 profiles

Complex heatmaps reveal patterns and correlations in 804 multidimensional genomic data

A new mathematical model for relative quantification in real-time RT-PCR